BMB Reports : eISSN 1976-670X

Cited by CrossRef (8)

  1. Yumin Wang, Xiaorui Wu, Zhao Ren, Yulin Li, Wailong Zou, Jichao Chen, Hongquan Wang. Overcoming cancer chemotherapy resistance by the induction of ferroptosis. Drug Resistance Updates 2023;66:100916
    https://doi.org/10.1016/j.drup.2022.100916
  2. Ruoxi Zhang, Rui Kang, Daolin Tang. Ferroptosis in gastrointestinal cancer: from mechanisms to implications. Cancer Letters 2023;561:216147
    https://doi.org/10.1016/j.canlet.2023.216147
  3. Qiuhong Li, Kexin Chen, Tianyi Zhang, Donghui Jiang, Ligang Chen, Jun Jiang, Chunxiang Zhang, Shengbiao Li. Understanding sorafenib-induced ferroptosis and resistance mechanisms: Implications for cancer therapy. European Journal of Pharmacology 2023;955:175913
    https://doi.org/10.1016/j.ejphar.2023.175913
  4. Xudong Zhu, Shenglong Li. Ferroptosis, Necroptosis, and Pyroptosis in Gastrointestinal Cancers: The Chief Culprits of Tumor Progression and Drug Resistance. Advanced Science 2023;10
    https://doi.org/10.1002/advs.202300824
  5. Zijian Wang, Chunyang Zhou, Yiming Zhang, Xinchen Tian, Haochen Wang, Jibiao Wu, Shulong Jiang. From synergy to resistance: Navigating the complex relationship between sorafenib and ferroptosis in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 2024;170:116074
    https://doi.org/10.1016/j.biopha.2023.116074
  6. Wen Lai, Jianquan Chen, Tianming Wang, Qiaoling Liu. Crosstalk between ferroptosis and steroid hormone signaling in gynecologic cancers. Front. Mol. Biosci. 2023;10
    https://doi.org/10.3389/fmolb.2023.1223493
  7. Jiao Sun, Qi Liu, Yanfang Jiang, Zhihui Cai, Hui Liu, Huaiwen Zuo. Engineered small extracellular vesicles loaded with miR-654-5p promote ferroptosis by targeting HSPB1 to alleviate sorafenib resistance in hepatocellular carcinoma. Cell Death Discov. 2023;9
    https://doi.org/10.1038/s41420-023-01660-2
  8. Soon-Young Na, Ki-Sun Kim, Yoon Seok Jung, Don-Kyu Kim, Jina Kim, Sung Jin Cho, In-Kyu Lee, Jongkyeong Chung, Jeong-Sun Kim, Hueng-Sik Choi. An Inverse Agonist GSK5182 Increases Protein Stability of the Orphan Nuclear Receptor ERRĪ³ via Inhibition of Ubiquitination. IJMS 2022;24:96
    https://doi.org/10.3390/ijms24010096